ArticlePharmacoEconomics2016

Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.

Melanie J Davies et al.PubMed ↗Publisher ↗

No numbers read from the abstract.